New Delhi: India's pharmaceutical exports to the United Kingdom are projected to grow by 8.66 per cent to reach $981.16 million in FY2026-27. The projection follows the implementation of the India-UK Comprehensive Economic and Trade Agreement (CETA).
According to a release from the Pharmaceuticals Export Promotion Council of India (Pharmexcil), the forecast builds on an export performance of $902.96 million recorded in FY2025-26. The upward trend continues in the current financial year, with shipments rising 4.15 per cent year-on-year (YoY) to $152.14 million during the April-May period, up from $146.08 million in the same months last year.
